Medical Devices Investors & VC Firms in United States
1104 firms in this list, with a median first check of $500K. 275 of them lead rounds. Generated from verified public data and updated continuously.
QuestMark Partners
BaltimoreGrowth$5M – $15M
7 people
Next Ventures
AustinSeed–Series A$500K – $3M
9 people
Delaware Crossing Investor Group
PhiladelphiaSeed–Series A
5 people
Taiwan Global Angels
BerkeleyPre-Seed–Growth$300K – $3M
19 people
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Eaton Square
Los AngelesSeries A–Growth
26 people
Sonder Capital
San CarlosPre-Seed–Series C
17 people
Innoventures Iowa
IowaPre-Seed–Seed
13 people
Oberland Capital
New YorkGrowth–Late Stage
20 people
Accelmed Partners
MiamiSeries A–Growth
10 people
Cloud Health Euroventures
ManchesterPre-Seed–Series A$100K – $1M
22 people
Cybernetix Ventures
BostonPre-Seed–Series A$60K – $500K
18 people
Nueterra Capital
LeawoodSeed–Growth
12 people
Oncology Ventures
New YorkSeed–Series A
17 people
Seaside Ventures
BoulderPre-Seed–Series A$250K
14 people
BIOSPRING PARTNERS
New YorkGrowth
22 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
Allumia Ventures
SeattleSeries A–Series C$5M – $15M
13 people
Avalon BioVentures
San DiegoPre-Seed–Seed
18 people
Bios Partners
Fort WorthSeed–Growth
17 people
Catalytic Impact Foundation
HinghamPre-Seed–Series A
8 people
Mission Bay Capital
San FranciscoPre-Seed–Series A
14 people
Kairos Venture Investments, Llc
Beverly HillsPre-Seed–Series A$150K – $20M
11 people
Mountain Group Capital
NashvillePre-Seed–Seed
13 people
Related lists
Investors & VC Firms in North America (13286)Investors & VC Firms in United States (12284)Investors & VC Firms in Europe (6052)AI & Machine Learning Investors & VC Firms (5303)Investors & VC Firms in Global (5278)Fintech Investors & VC Firms (5112)Healthtech Investors & VC Firms (4639)SaaS Investors & VC Firms (4498)Enterprise Software Investors & VC Firms (4394)Crypto & Web3 Investors & VC Firms (4130)
Data sourced from public filings and firms' own websites — see our methodology.











































































































